Baxter faces EU antitrust worries; Medicare cuts could hamper dialysis dollars;

 @FierceMedDev: Europe tables vote on tougher device regs. More | Follow @FierceMedDev

 @MarkHFierce:  We want your FMD Fierce 15 nominations. Send them in! More | Follow @MarkHFierce

 @DamianFierce: Theragenics has signed a deal to get its brachytherapy products on the market in the EU. Story | Follow @DamianFierce

 @MichaelGFierce: ICYMI: Avanir drops $110M on novel inhaled-delivery migraine device. Article | Follow @MichaelGFierce

> The FDA and the American Academy of Ophthalmology will sponsor a workshop on Oct. 11 designed to find ways to bring optical medical devices to market more quickly. Item

> Baxter ($BAX) reportedly is offering a number of concessions to the European Commission to ease antitrust concerns over its planned $4 billion merger with the Swedish dialysis company Gambro. Item

> CorMedix won a CE mark for its Neutrolin catheter lock, designed to cut the risk of bloodstream infections. More

> Seeking Alpha wrote a bullish piece on Nanosphere ($NSPH), a maker of molecular diagnostics that rely on gold nanoparticles. Item

> Makers of dialysis machines could see a 9.4% cut in Medicare payments--fallout from federal deficit-cutting efforts. Story

Biotech News

 @FierceBiotech:  SEC hunting down traders who made a quick killing on Onyx shares. Report | Follow @FierceBiotech

 @JohnCFierce:  Orexo stakes out $500M market for new opioid-addiction drug. More | Follow @JohnCFierce

 @RyanMFierce:  Xoma staffers form biotech startup to advance blood pressure med. News | Follow @RyanMFierce

 @EmilyMFierce:  In case you missed it over the holiday... Scientists create first regulatory map of tuberculosis. Report | Follow @EmilyMFierce

> Scientists score stem-cell victory with lab-grown liver tissue. Story

> Sarepta readies $125M raise to back muscular dystrophy drug work. Item

> Belgian biotech Cardio3 completes modest IPO. More

Pharma News

 @FiercePharma:  FDA to update generic labeling rules. Article | Follow @FiercePharma

 @CarlyHFierce: ICYMI: Glass particles trigger another Fresenius Kabi recall. Story | Follow @CarlyHFierce

>  Novartis' Lucentis gets its fourth approval in EU. News

> Orexo gets FDA approval for opioid addiction-fighting Zubsolv. Story

> Fresenius gets warning letter for India plant. More

Vaccines News

> Reliance on NIH threatens HIV vaccine funding. Story

> Polio discovery prompts Israeli vaccination push. More

> Merck KGaA: Lung cancer vaccine not dead. Article

> Study: Use of 2D barcodes could save healthcare $300M. News

> Novartis and Sanofi nab DoD vaccine contracts. Item

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.